Search

Your search keyword '"Axcrona, Ulrika"' showing total 16 results
Start Over Author "Axcrona, Ulrika" Search Limiters Full Text
16 results on '"Axcrona, Ulrika"'

8. Collision tumors revealed by prospectively assessing subtype-defining molecular alterations in 904 individual prostate cancer foci

Author

Fontugne, Jacqueline, primary, Cai, Peter Y., additional, Alnajar, Hussein, additional, Bhinder, Bhavneet, additional, Park, Kyung, additional, Ye, Huihui, additional, Beg, Shaham, additional, Sailer, Verena, additional, Siddiqui, Javed, additional, Blattner-Johnson, Mirjam, additional, Croyle, Jaclyn A., additional, Noorzad, Zohal, additional, Calagua, Carla, additional, MacDonald, Theresa Y., additional, Axcrona, Ulrika, additional, Bogaard, Mari, additional, Axcrona, Karol, additional, Scherr, Douglas S., additional, Sanda, Martin G., additional, Johannessen, Bjarne, additional, Chinnaiyan, Arul M., additional, Elemento, Olivier, additional, Skotheim, Rolf I., additional, Rubin, Mark A., additional, Barbieri, Christopher E., additional, and Mosquera, Juan Miguel, additional

Published
2022
Full Text
View/download PDF

10. Overall survival in renal cell carcinoma after introduction of targeted therapies: a Norwegian population-based study

Author

Beisland,Christian, Johannesen,Tom, Klepp,Olbjorn, Axcrona,Ulrika, Torgersen,Knut Martin, Kowalski,Jan, Solli,Oddvar, Sandin,Rickard, Oldenburg,Jan, Beisland,Christian, Johannesen,Tom, Klepp,Olbjorn, Axcrona,Ulrika, Torgersen,Knut Martin, Kowalski,Jan, Solli,Oddvar, Sandin,Rickard, and Oldenburg,Jan

Abstract

Christian Beisland,1,2 Tom B Johannesen,3 Olbjorn Klepp,4 Ulrika Axcrona,5 Knut Martin Torgersen,6 Jan Kowalski,7 Oddvar Solli,6 Rickard Sandin,8 Jan Oldenburg9,10 1Department of Urology, Haukeland University Hospital, 2Department of Clinical Medicine, University of Bergen, Bergen, 3Department of Registration, Cancer Registry of Norway, Oslo, 4Department of Oncology, Ålesund Hospital, Ålesund, 5Department of Pathology, Oslo University Hospital, the Norwegian Radium Hospital, Oslo, 6Pfizer AS, Oslo, Norway; 7JK Biostatistics AB, Stockholm, 8Pfizer AB, Sollentuna, Sweden; 9Department of Oncology, Akershus University Hospital, Lørenskog, 10Medical Faculty, University of Oslo, Oslo, Norway Background: This population-wide retrospective, non-interventional registry study assessed changes in overall survival (OS) and factors influencing OS in Norwegian patients with renal cell carcinoma (RCC). Methods: Two population-wide health registries were used to identify all RCC patients with (mRCC) or without metastases diagnosed before (2002–2005) and after (2006–2008 and 2009–2011) introduction of targeted therapies. Median OS was estimated using Kaplan–Meier method. Cox proportional hazards regression modeling was used to identify prognostic factors. Results: Overall, 5,463 patients were diagnosed with RCC during 2002–2005 (n=1,898), 2006–2008 (n=1,631), and 2009–2011 (n=1,934); of these, 1,678 (31%) had mRCC. Patients diagnosed in 2009–2011 and 2006–2008 had significant (P<0.001) improvements in OS versus those diagnosed in 2002–2005: median OS, not reached and not reached versus 82.0 months in RCC; 14.0 and 12.0 months versus 9.0 months in mRCC. Similarly, OS improvements were seen in the primary and elderly (≥75 years) mRCC populations. Median OS was comparable (12 months) between clear c

Published
2017

12. Dendritic and lymphocytic cell infiltration in prostate carcinoma

Author

Yishan, Liu, Thorstein, Sæter, Vlatkovic, Ljiljana, Servoll, Einar, Waaler, Gudmund, Axcrona, Ulrika, Giercksky, Karl- Erik, Nesland, Jahn M., Zhen-He, Suo, and Axcrona, Karol

Subjects
Prostate cancer, 5 - Ciencias puras y naturales::57 - Biología::576 - Biología celular y subcelular. Citología [CDU], CD1a
Abstract

We examined the distribution of CD1a+ cells and CD8+ and CD4+ T lymphocytes in prostate cancer (PCa) and correlated these with clinicopathological parameters. We also investigated whether the distribution of these cells was related to the expression of the cell membrane protein B7-H3, a putative negative regulator of the immune response expressed on PCa cells. A cohort of 151 PCa patients treated with radical prostatectomy (RP) was followed prospectively from 1985 until 2006 with a median follow-up of 9 years. Whole-mount sections of PCa specimens were immunostained to identify immune cells. A low number of CD1a+ cells was significantly associated with a high Gleason score and high pathological stage of pT3. The number of CD1a+ cells correlated significantly with the number of intratumoral and stromal CD8+ and stromal CD4+ lymphocytes. Kaplan-Meier analysis showed a tendency toward impaired biochemical progression-free survival in patients with few CD1a+ cells within their RP specimens. The expression of B7-H3 correlated inversely with the number of CD1a+ cells and intratumoral CD4+ lymphocytes; there was a trend for a similar inverse relationship between B7-H3 expression and the number of CD8+ lymphocytes. Our findings suggest that high-grade prostate carcinoma cells manipulate the immune system and that these changes contribute to the mechanism underlying tumor escape from immune surveillance.

Published
2013

13. Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT Study

Author

Bancroft, Elizabeth K., Page, Elizabeth C., Castro, Elena, Lilja, Hans, Vickers, Andrew, Sjoberg, Daniel, Assel, Melissa, Foster, Christopher S., Mitchell, Gillian, Drew, Kate, Maehle, Lovise, Axcrona, Karol, Evans, D. Gareth, Bulman, Barbara, Eccles, Diana, McBride, Donna, van Asperen, Christi, Vasen, Hans, Kiemeney, Lambertus A., Ringelberg, Janneke, Cybulski, Cezary, Wokolorczyk, Dominika, Selkirk, Christina, Hulick, Peter J., Bojesen, Anders, Skytte, Anne-Bine, Lam, Jimmy, Taylor, Louise, Oldenburg, Rogier, Cremers, Ruben, Verhaegh, Gerald, van Zelst-Stams, Wendy A., Oosterwijk, Jan C., Blanco, Ignacio, Salinas, Monica, Cook, Jackie, Rosario, Derek J., Buys, Saundra, Conner, Tom, Ausems, Margreet G., Ong, Kai-ren, Hoffman, Jonathan, Domchek, Susan, Powers, Jacquelyn, Teixeira, Manuel R., Maia, Sofia, Foulkes, William D., Taherian, Nassim, Ruijs, Marielle, Helderman-van den Enden, Apollonia T., Izatt, Louise, Davidson, Rosemarie, Adank, Muriel A., Walker, Lisa, Schmutzler, Rita, Tucker, Kathy, Kirk, Judy, Hodgson, Shirley, Harris, Marion, Douglas, Fiona, Lindeman, Geoffrey J., Zgajnar, Janez, Tischkowitz, Marc, Clowes, Virginia E., Susman, Rachel, Ramon y Cajal, Teresa, Patcher, Nicholas, Gadea, Neus, Spigelman, Allan, van Os, Theo, Liljegren, Annelie, Side, Lucy, Brewer, Carole, Brady, Angela F., Donaldson, Alan, Stefansdottir, Vigdis, Friedman, Eitan, Chen-Shtoyerman, Rakefet, Amor, David J., Copakova, Lucia, Barwell, Julian, Giri, Veda N., Murthy, Vedang, Nicolai, Nicola, Teo, Soo-Hwang, Greenhalgh, Lynn, Strom, Sara, Henderson, Alex, McGrath, John, Gallagher, David, Aaronson, Neil, Ardern-Jones, Audrey, Bangma, Chris, Dearnaley, David, Costello, Philandra, Eyfjord, Jorunn, Rothwell, Jeanette, Falconer, Alison, Gronberg, Henrik, Hamdy, Freddie C., Johannsson, Oskar, Khoo, Vincent, Kote-Jarai, Zsofia, Lubinski, Jan, Axcrona, Ulrika, Melia, Jane, McKinley, Joanne, Mitra, Anita V., Moynihan, Clare, Rennert, Gad, Suri, Mohnish, Wilson, Penny, Killick, Emma, Moss, Sue, Eeles, Rosalind A., Taylor, Natalie, Pope, Jenny, Saya, Sibel, Martin, Sue, Keating, Diana, Petelin, Lara, Murphy, Morgan, Doherty, Rebecca, Pratt, Sarah, Murphy, Declan, Cleeve, Laurence, Miller, Cathy, Stapleton, Alan, Chong, Michael, Suthers, Graeme, Tucker, Katherine, Andrews, Lesley, Duffy, Jessica, Millard, Richard, Ward, Robyn, Williams, Rachel, Stricker, Phillip, Bowman, Michelle, Patel, Manish, O'Connell, Shona, Hunt, Clare, Smyth, Courtney, Frydenberg, Mark, Shackleton, Kylie, McGaughran, Julie, Boon, Melanie, Pachter, Nicholas, Townshend, Sharron, Schofield, Lyn, Gleeson, Margaret, Scott, Rodney, Burke, Jo, Patterson, Briony, Bacic, Sonya, Swindle, Peter, Aprikian, Armen, Bojeson, Anders, Cruger, Dorthe, Osther, Palle, Gerdes, Anne-Marie, Rhiem, Kerstin, Luedtke-Heckenkamp, Kerstin, Ochsendorf, Nicole, Fiddike, Kerstin, Sarin, Rajiv, Awatagiri, Kasturi, Ghonge, Sujata, Kowtal, Pradnya, Mulgund, Gouri, Bambury, Richard, Farrell, Michael, Gallagher, Fergal, Ben-Yehoshua, Sagi Josefsberg, Nissani, Rachel, Appelman, Zvi, Moriel, Evyatar, Radice, Paolo, Valdagni, Riccardo, Magnani, Tiziana, Meng, Tan Hui, Yoon, Sook-Yee, Thong, Meow Keong, Kiemeney, Bart, Van der Luijt, Rob B., Moller, Pal, Brennhovd, Bjorn, Medvik, Heidi, Hanslien, Eldbjorg, Peixoto, Ana, Henrique, Rui, Oliveira, Jorge, Goncalves, Nuno, Araujo, Luis, Seixas, Manuela, Souto Joao, Paulo, Nogueira, Pedro, Krajc, Mateja, Vrecar, Alenka, Capella, Gabriel, Fisas, David, Balmana, Judith, Morote, Juan, Hjalm-Eriksson, Marie, Ekdahl, Karl-Johan, Carlsson, Stefan, Hanson, Helen, Shanley, Susan, Goh, Chee, Wiggins, Jennifer, Kohut, Kelly, Van As, Nicholas, Thompson, Alan, Ogden, Chris, Borley, Nigel, Woodhouse, Christopher, Kumar, Pardeep, Mercer, Catherine, Paterson, Joan, Taylor, Amy, Newcombe, Barbara, Halliday, Dorothy, Stayner, Barbara, Fleming-Brown, D., Brice, Glen, Homfray, Tessa, Hammond, Carrie, Potter, Alison, Renton, Caroline, Searle, Anne, Hill, Kathryn, Goodman, Selina, Garcia, Lynda, Devlin, Gemma, Everest, Sarah, Nadolski, Maria, Jobson, Irene, Paez, Edgar, Tomkins, Sue, Pichert, Gabriella, Jacobs, Chris, Langman, Caroline, Weston, Michelle, Dorkins, Huw, Melville, Athalie, Kosicka-Slawinska, Monika, Cummings, Carole, Kiesel, Vicki, Bartlett, Marion, Randhawa, Kashmir, Ellery, Natalie, Male, Alison, Simon, Kate, Rees, Katie, Compton, Cecilia, Tidey, Lizzie, Nevitt, Louise, Ingram, Stuart, Catto, James, Howson, Joanne, Chapman, Cyril, Cole, Trevor, Heaton, Tricia, Burgess, Lucy, Longmuir, Mark, Watt, Cathy, Duncan, Alexis, Kockelbergh, Roger, Sattar, Ayisha, Kaemba, Beckie, Sidat, Zahirah, Patel, Nafisa, Siguake, Kas, Birt, Angela, Poultney, Una, Umez-Eronini, Nkem, Mom, Jaswant, Roberts, Gillian, Woodward, Anthony, Sutton, Vivienne, Cornford, Philip, Treherne, Katy, Griffiths, Julie, Cogley, Lyn, Rubinstein, Wendy, Brendler, Charles, Helfand, Brian, McGuire, Michael, Kaul, Karen, Shevrin, Daniel, Weissman, Scott, Newlin, Anna, Vogel, Kristen, Weiss, Shelly, Goldgar, David, Venne, Vickie, Stephenson, Robert, Dechet, Christopher, Arun, Banu, Davis, John W., Yamamura, Yuko, Gross, Laura, Bancroft, Elizabeth K., Page, Elizabeth C., Castro, Elena, Lilja, Hans, Vickers, Andrew, Sjoberg, Daniel, Assel, Melissa, Foster, Christopher S., Mitchell, Gillian, Drew, Kate, Maehle, Lovise, Axcrona, Karol, Evans, D. Gareth, Bulman, Barbara, Eccles, Diana, McBride, Donna, van Asperen, Christi, Vasen, Hans, Kiemeney, Lambertus A., Ringelberg, Janneke, Cybulski, Cezary, Wokolorczyk, Dominika, Selkirk, Christina, Hulick, Peter J., Bojesen, Anders, Skytte, Anne-Bine, Lam, Jimmy, Taylor, Louise, Oldenburg, Rogier, Cremers, Ruben, Verhaegh, Gerald, van Zelst-Stams, Wendy A., Oosterwijk, Jan C., Blanco, Ignacio, Salinas, Monica, Cook, Jackie, Rosario, Derek J., Buys, Saundra, Conner, Tom, Ausems, Margreet G., Ong, Kai-ren, Hoffman, Jonathan, Domchek, Susan, Powers, Jacquelyn, Teixeira, Manuel R., Maia, Sofia, Foulkes, William D., Taherian, Nassim, Ruijs, Marielle, Helderman-van den Enden, Apollonia T., Izatt, Louise, Davidson, Rosemarie, Adank, Muriel A., Walker, Lisa, Schmutzler, Rita, Tucker, Kathy, Kirk, Judy, Hodgson, Shirley, Harris, Marion, Douglas, Fiona, Lindeman, Geoffrey J., Zgajnar, Janez, Tischkowitz, Marc, Clowes, Virginia E., Susman, Rachel, Ramon y Cajal, Teresa, Patcher, Nicholas, Gadea, Neus, Spigelman, Allan, van Os, Theo, Liljegren, Annelie, Side, Lucy, Brewer, Carole, Brady, Angela F., Donaldson, Alan, Stefansdottir, Vigdis, Friedman, Eitan, Chen-Shtoyerman, Rakefet, Amor, David J., Copakova, Lucia, Barwell, Julian, Giri, Veda N., Murthy, Vedang, Nicolai, Nicola, Teo, Soo-Hwang, Greenhalgh, Lynn, Strom, Sara, Henderson, Alex, McGrath, John, Gallagher, David, Aaronson, Neil, Ardern-Jones, Audrey, Bangma, Chris, Dearnaley, David, Costello, Philandra, Eyfjord, Jorunn, Rothwell, Jeanette, Falconer, Alison, Gronberg, Henrik, Hamdy, Freddie C., Johannsson, Oskar, Khoo, Vincent, Kote-Jarai, Zsofia, Lubinski, Jan, Axcrona, Ulrika, Melia, Jane, McKinley, Joanne, Mitra, Anita V., Moynihan, Clare, Rennert, Gad, Suri, Mohnish, Wilson, Penny, Killick, Emma, Moss, Sue, Eeles, Rosalind A., Taylor, Natalie, Pope, Jenny, Saya, Sibel, Martin, Sue, Keating, Diana, Petelin, Lara, Murphy, Morgan, Doherty, Rebecca, Pratt, Sarah, Murphy, Declan, Cleeve, Laurence, Miller, Cathy, Stapleton, Alan, Chong, Michael, Suthers, Graeme, Tucker, Katherine, Andrews, Lesley, Duffy, Jessica, Millard, Richard, Ward, Robyn, Williams, Rachel, Stricker, Phillip, Bowman, Michelle, Patel, Manish, O'Connell, Shona, Hunt, Clare, Smyth, Courtney, Frydenberg, Mark, Shackleton, Kylie, McGaughran, Julie, Boon, Melanie, Pachter, Nicholas, Townshend, Sharron, Schofield, Lyn, Gleeson, Margaret, Scott, Rodney, Burke, Jo, Patterson, Briony, Bacic, Sonya, Swindle, Peter, Aprikian, Armen, Bojeson, Anders, Cruger, Dorthe, Osther, Palle, Gerdes, Anne-Marie, Rhiem, Kerstin, Luedtke-Heckenkamp, Kerstin, Ochsendorf, Nicole, Fiddike, Kerstin, Sarin, Rajiv, Awatagiri, Kasturi, Ghonge, Sujata, Kowtal, Pradnya, Mulgund, Gouri, Bambury, Richard, Farrell, Michael, Gallagher, Fergal, Ben-Yehoshua, Sagi Josefsberg, Nissani, Rachel, Appelman, Zvi, Moriel, Evyatar, Radice, Paolo, Valdagni, Riccardo, Magnani, Tiziana, Meng, Tan Hui, Yoon, Sook-Yee, Thong, Meow Keong, Kiemeney, Bart, Van der Luijt, Rob B., Moller, Pal, Brennhovd, Bjorn, Medvik, Heidi, Hanslien, Eldbjorg, Peixoto, Ana, Henrique, Rui, Oliveira, Jorge, Goncalves, Nuno, Araujo, Luis, Seixas, Manuela, Souto Joao, Paulo, Nogueira, Pedro, Krajc, Mateja, Vrecar, Alenka, Capella, Gabriel, Fisas, David, Balmana, Judith, Morote, Juan, Hjalm-Eriksson, Marie, Ekdahl, Karl-Johan, Carlsson, Stefan, Hanson, Helen, Shanley, Susan, Goh, Chee, Wiggins, Jennifer, Kohut, Kelly, Van As, Nicholas, Thompson, Alan, Ogden, Chris, Borley, Nigel, Woodhouse, Christopher, Kumar, Pardeep, Mercer, Catherine, Paterson, Joan, Taylor, Amy, Newcombe, Barbara, Halliday, Dorothy, Stayner, Barbara, Fleming-Brown, D., Brice, Glen, Homfray, Tessa, Hammond, Carrie, Potter, Alison, Renton, Caroline, Searle, Anne, Hill, Kathryn, Goodman, Selina, Garcia, Lynda, Devlin, Gemma, Everest, Sarah, Nadolski, Maria, Jobson, Irene, Paez, Edgar, Tomkins, Sue, Pichert, Gabriella, Jacobs, Chris, Langman, Caroline, Weston, Michelle, Dorkins, Huw, Melville, Athalie, Kosicka-Slawinska, Monika, Cummings, Carole, Kiesel, Vicki, Bartlett, Marion, Randhawa, Kashmir, Ellery, Natalie, Male, Alison, Simon, Kate, Rees, Katie, Compton, Cecilia, Tidey, Lizzie, Nevitt, Louise, Ingram, Stuart, Catto, James, Howson, Joanne, Chapman, Cyril, Cole, Trevor, Heaton, Tricia, Burgess, Lucy, Longmuir, Mark, Watt, Cathy, Duncan, Alexis, Kockelbergh, Roger, Sattar, Ayisha, Kaemba, Beckie, Sidat, Zahirah, Patel, Nafisa, Siguake, Kas, Birt, Angela, Poultney, Una, Umez-Eronini, Nkem, Mom, Jaswant, Roberts, Gillian, Woodward, Anthony, Sutton, Vivienne, Cornford, Philip, Treherne, Katy, Griffiths, Julie, Cogley, Lyn, Rubinstein, Wendy, Brendler, Charles, Helfand, Brian, McGuire, Michael, Kaul, Karen, Shevrin, Daniel, Weissman, Scott, Newlin, Anna, Vogel, Kristen, Weiss, Shelly, Goldgar, David, Venne, Vickie, Stephenson, Robert, Dechet, Christopher, Arun, Banu, Davis, John W., Yamamura, Yuko, and Gross, Laura

Abstract

Background: Men with germline breast cancer 1, early onset (BRCA1) or breast cancer 2, early onset (BRCA2) gene mutations have a higher risk of developing prostate cancer (PCa) than noncarriers. IMPACT (Identification of Men with a genetic predisposition to ProstAte Cancer: Targeted screening in BRCA1/2 mutation carriers and controls) is an international consortium of 62 centres in 20 countries evaluating the use of targeted PCa screening in men with BRCA1/2 mutations. Objective: To report the first year's screening results for all men at enrolment in the study. Design, setting and participants: We recruited men aged 40-69 yr with germline BRCA1/2 mutations and a control group of men who have tested negative for a pathogenic BRCA1 or BRCA2 mutation known to be present in their families. All men underwent prostate-specific antigen (PSA) testing at enrolment, and those men with PSA > 3 ng/ml were offered prostate biopsy. Outcome measurements and statistical analysis: PSA levels, PCa incidence, and tumour characteristics were evaluated. The Fisher exact test was used to compare the number of PCa cases among groups and the differences among disease types. Results and limitations: We recruited 2481 men (791 BRCA1 carriers, 531 BRCA1 controls; 731 BRCA2 carriers, 428 BRCA2 controls). A total of 199 men (8%) presented with PSA > 3.0 ng/ml, 162 biopsies were performed, and 59 PCas were diagnosed (18 BRCA1 carriers, 10 BRCA1 controls; 24 BRCA2 carriers, 7 BRCA2 controls); 66% of the tumours were classified as intermediate-or high-risk disease. The positive predictive value (PPV) for biopsy using a PSA threshold of 3.0 ng/ml in BRCA2 mutation carriers was 48%-double the PPV reported in population screening studies. A significant difference in detecting intermediate-or high-risk disease was observed in BRCA2 carriers. Ninety-five percent of the men were white, thus the results cannot be generalised to all ethnic groups. Conclusions: The IMPACT screening network will be useful

Published
2014

14. SHBG Is an Important Factor in Stemness Induction of Cells by DHT In Vitro and Associated with Poor Clinical Features of Prostate Carcinomas

Author

Ma, Yuanyuan, primary, Liang, Dongming, additional, Liu, Jian, additional, Wen, Jian-Guo, additional, Servoll, Einar, additional, Waaler, Gudmund, additional, Sæter, Thorstein, additional, Axcrona, Karol, additional, Vlatkovic, Ljiljana, additional, Axcrona, Ulrika, additional, Paus, Elisabeth, additional, Yang, Yue, additional, Zhang, Zhiqian, additional, Kvalheim, Gunnar, additional, Nesland, Jahn M., additional, and Suo, Zhenhe, additional

Published
2013
Full Text
View/download PDF

16. SHBG Is an Important Factor in Stemness Induction of Cells by DHT In Vitro and Associated with Poor Clinical Features of Prostate Carcinomas.

Author

Ma, Yuanyuan, Liang, Dongming, Liu, Jian, Wen, Jian-Guo, Servoll, Einar, Waaler, Gudmund, Sæter, Thorstein, Axcrona, Karol, Vlatkovic, Ljiljana, Axcrona, Ulrika, Paus, Elisabeth, Yang, Yue, Zhang, Zhiqian, Kvalheim, Gunnar, Nesland, Jahn M., and Suo, Zhenhe

Subjects
PROSTATE cancer, GENE expression, IMMUNOHISTOCHEMISTRY, ENDOCRINE gland physiology, CELLULAR signal transduction, GENITOURINARY organ tumors
Abstract

Androgen plays a vital role in prostate cancer development. However, it is not clear whether androgens influence stem-like properties of prostate cancer, a feature important for prostate cancer progression. In this study, we show that upon DHT treatment in vitro, prostate cancer cell lines LNCaP and PC-3 were revealed with higher clonogenic potential and higher expression levels of stemness related factors CD44, CD90, Oct3/4 and Nanog. Moreover, sex hormone binding globulin (SHBG) was also simultaneously upregulated in these cells. When the SHBG gene was blocked by SHBG siRNA knock-down, the induction of Oct3/4, Nanog, CD44 and CD90 by DHT was also correspondingly blocked in these cells. Immunohistochemical evaluation of clinical samples disclosed weakly positive, and areas negative for SHBG expression in the benign prostate tissues, while most of the prostate carcinomas were strongly positive for SHBG. In addition, higher levels of SHBG expression were significantly associated with higher Gleason score, more seminal vesicle invasions and lymph node metastases. Collectively, our results show a role of SHBG in upregulating stemness of prostate cancer cells upon DHT exposure in vitro, and SHBG expression in prostate cancer samples is significantly associated with poor clinicopathological features, indicating a role of SHBG in prostate cancer progression. [ABSTRACT FROM AUTHOR]

Published
2013
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results